Toll‐like receptors: the swiss army knife of immunity and vaccine development
JK Dowling, A Mansell - Clinical & translational immunology, 2016 - Wiley Online Library
Innate immune cells have a critical role in defense against infection and disease. Central to
this is the broad specificity with which they can detect pathogen‐associated patterns and …
this is the broad specificity with which they can detect pathogen‐associated patterns and …
Structure-dependent immunostimulatory effect of CpG oligodeoxynucleotides and their delivery system
N Hanagata - International journal of nanomedicine, 2012 - Taylor & Francis
Unmethylated cytosine-phosphate-guanosine (CpG) oligodeoxynucleotides (ODNs) are
recognized by Toll-like receptor 9 (TLR9) found in antigen-presenting cells and B cells and …
recognized by Toll-like receptor 9 (TLR9) found in antigen-presenting cells and B cells and …
Organelle-specific triggered release of immunostimulatory oligonucleotides from intrinsically coordinated DNA–metal–organic frameworks with soluble exoskeleton
DNA has proven of high utility to modulate the surface functionality of metal–organic
frameworks (MOFs) for various biomedical applications. Nevertheless, current methods for …
frameworks (MOFs) for various biomedical applications. Nevertheless, current methods for …
Improving multi-epitope long peptide vaccine potency by using a strategy that enhances CD4+ T help in BALB/c mice
H Ghaffari-Nazari, J Tavakkol-Afshari, MR Jaafari… - PloS one, 2015 - journals.plos.org
Peptide-based vaccines are attractive approaches for cancer immunotherapy; but the
success of these vaccines in clinical trials have been limited. Our goal is to improve immune …
success of these vaccines in clinical trials have been limited. Our goal is to improve immune …
DNA nanotubes as intracellular delivery vehicles in vivo
DNA-based nanoconstructs possess great potential for biomedical applications. However,
the in vivo behavior of such constructs at the microscopic tissue/cell level as well as their …
the in vivo behavior of such constructs at the microscopic tissue/cell level as well as their …
Nanodelivery systems for enhancing the immunostimulatory effect of CpG oligodeoxynucleotides
H Zhang, XD Gao - Materials Science and Engineering: C, 2017 - Elsevier
Synthetic oligodeoxynucleotides containing immunostimulatory CpG motif mimic bacterial
DNA and are potent activator of innate and adaptive immune responses. Therefore, CpG …
DNA and are potent activator of innate and adaptive immune responses. Therefore, CpG …
Preparation, characterization, and evaluation of chitosan-based nanoparticles as CpG ODN carriers
FC Iswanti, I Nurulita, S Djauzi, M Sadikin… - Biotechnology & …, 2019 - Taylor & Francis
Chitosan-based particles are desirable materials for drug delivery because of their muco-
adhesiveness in tissues, biocompatibility, low toxicity and effectiveness in antigen transport …
adhesiveness in tissues, biocompatibility, low toxicity and effectiveness in antigen transport …
Toll-like receptor-based adjuvants: enhancing the immune response to vaccines against infectious diseases of chicken
Huge productivity loss due to infectious diseases in chickens is a major problem and, hence,
robust development of the poultry industry requires control of poultry health. Immunization …
robust development of the poultry industry requires control of poultry health. Immunization …
Complexing CpG adjuvants with cationic liposomes enhances vaccine-induced formation of liver TRM cells
Tissue resident memory T cells (T RM cells) can provide effective tissue surveillance and
can respond rapidly to infection. Vaccination strategies aimed at generating T RM cells have …
can respond rapidly to infection. Vaccination strategies aimed at generating T RM cells have …
[HTML][HTML] Direct and indirect immune effects of CMP-001, a virus-like particle containing a TLR9 agonist
SA Sabree, AP Voigt, SE Blackwell… - … for immunotherapy of …, 2021 - ncbi.nlm.nih.gov
Background CMP-001, also known as vidutolimod, is a virus-like particle containing a TLR9
agonist that is showing promise in early clinical trials. Our group previously demonstrated …
agonist that is showing promise in early clinical trials. Our group previously demonstrated …